244 related articles for article (PubMed ID: 7507692)
1. Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.
Boxer GM; Abassi AM; Pedley RB; Begent RH
Br J Cancer; 1994 Feb; 69(2):307-14. PubMed ID: 7507692
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma--implications for radioimmunotherapy.
Boxer GM; Begent RH; Kelly AM; Southall PJ; Blair SB; Theodorou NA; Dawson PM; Ledermann JA
Br J Cancer; 1992 Jun; 65(6):825-31. PubMed ID: 1616854
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of PDGFR inhibition with imatinib on radiolabeled antibody targeting and clearance in two pathologically distinct models of colon adenocarcinoma.
Rajkumar VS; Boxer G; Robson M; Muddle J; Papastavrou Y; Pedley RB
Tumour Biol; 2012 Dec; 33(6):2019-29. PubMed ID: 22833213
[TBL] [Abstract][Full Text] [Related]
4. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
[TBL] [Abstract][Full Text] [Related]
5. The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.
Pedley RB; Boden JA; Boden R; Begent RH; Turner A; Haines AM; King DJ
Br J Cancer; 1994 Dec; 70(6):1126-30. PubMed ID: 7981064
[TBL] [Abstract][Full Text] [Related]
6. The spatial distribution of parenterally administered monoclonal antibodies against CEA in a human colorectal tumour xenograft.
Ahlström H; Enblad P; Andersson A; Lörelius LE
Acta Oncol; 1989; 28(1):81-6. PubMed ID: 2706137
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
Casey JL; King DJ; Chaplin LC; Haines AM; Pedley RB; Mountain A; Yarranton GT; Begent RH
Br J Cancer; 1996 Nov; 74(9):1397-405. PubMed ID: 8912535
[TBL] [Abstract][Full Text] [Related]
8. Adhesion to carcinoembryonic antigen by human colorectal carcinoma cells involves at least two epitopes.
Jessup JM; Kim JC; Thomas P; Ishii S; Ford R; Shively JE; Durbin H; Stanners CP; Fuks A; Zhou H
Int J Cancer; 1993 Sep; 55(2):262-8. PubMed ID: 7690347
[TBL] [Abstract][Full Text] [Related]
9. The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.
Pedley RB; Boden JA; Boden RW; Green A; Boxer GM; Bagshawe KD
Br J Cancer; 1989 Oct; 60(4):549-54. PubMed ID: 2803924
[TBL] [Abstract][Full Text] [Related]
10. Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material.
Webley SD; Francis RJ; Pedley RB; Sharma SK; Begent RH; Hartley JA; Hochhauser D
Br J Cancer; 2001 Jun; 84(12):1671-6. PubMed ID: 11401322
[TBL] [Abstract][Full Text] [Related]
11. Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.
Vogel CA; Bischof-Delaloye A; Mach JP; Pèlegrin A; Hardman N; Delaloye B; Buchegger F
Br J Cancer; 1993 Oct; 68(4):684-90. PubMed ID: 8398694
[TBL] [Abstract][Full Text] [Related]
12. Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy.
Fidarova EF; El-Emir E; Boxer GM; Qureshi U; Dearling JL; Robson MP; Begent RH; Trott KR; Pedley RB
Clin Cancer Res; 2008 May; 14(9):2639-46. PubMed ID: 18451227
[TBL] [Abstract][Full Text] [Related]
13. Target mediated disposition of T84.66, a monoclonal anti-CEA antibody: application in the detection of colorectal cancer xenografts.
Urva SR; Balthasar JP
MAbs; 2010; 2(1):67-72. PubMed ID: 20081377
[TBL] [Abstract][Full Text] [Related]
14. Mapping of monoclonal antibody-defined epitopes associated with carcinoembryonic antigen, CEA.
Price MR; Edwards S; Jacobs E; Pawluczyk IZ; Byers VS; Baldwin RW
Cancer Immunol Immunother; 1987; 25(1):10-5. PubMed ID: 2439201
[TBL] [Abstract][Full Text] [Related]
15. Comparison of anti-fetal colonic microvillus and anti-CEA antibodies in peroperative radioimmunolocalisation of colorectal cancer.
Blair SD; Theodorou NA; Begent RH; Dawson PM; Salmon M; Riggs S; Kelly A; Boxer G; Southall P; Gregory P
Br J Cancer; 1990 Jun; 61(6):891-4. PubMed ID: 2372492
[TBL] [Abstract][Full Text] [Related]
16. Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies.
Primus FJ; Kuhns WJ; Goldenberg DM
Cancer Res; 1983 Feb; 43(2):693-701. PubMed ID: 6184153
[TBL] [Abstract][Full Text] [Related]
17. Physiological factors influencing radioantibody uptake: a study of four human colonic carcinomas.
Blumenthal RD; Sharkey RM; Kashi R; Natale AM; Goldenberg DM
Int J Cancer; 1992 Jul; 51(6):935-41. PubMed ID: 1322378
[TBL] [Abstract][Full Text] [Related]
18. Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.
Corvalan JR; Smith W; Gore VA; Brandon DR
Cancer Immunol Immunother; 1987; 24(2):133-7. PubMed ID: 3829047
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
Kuroki M; Kuroki M; Koga Y; Matsuoka Y
J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
[TBL] [Abstract][Full Text] [Related]
20. The comparative distribution of monoclonal antibodies to CEA in colorectal xenografts.
Lewis JC; Boxer GM; Searle F; Bagshawe KD
Tumour Biol; 1984; 5(5):255-61. PubMed ID: 6397841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
